These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7585976)

  • 1. Interleukin-12 is a costimulatory cytokine for leukemic CD3+ large granular lymphocytes.
    Gentile TC; Loughran TP
    Cell Immunol; 1995 Nov; 166(1):158-61. PubMed ID: 7585976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation signals leading to proliferation of normal and leukemic CD3+ large granular lymphocytes.
    Aprile JA; Russo M; Pepe MS; Loughran TP
    Blood; 1991 Sep; 78(5):1282-5. PubMed ID: 1831681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of NK activity in large granular lymphocyte leukemia: activation with anti-CD3 monoclonal antibody and interleukin 2.
    Loughran TP; Draves KE; Starkebaum G; Kidd P; Clark EA
    Blood; 1987 Jan; 69(1):72-8. PubMed ID: 3098327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-2 receptor monoclonal antibodies have no effect on anti-CD3 monoclonal antibody-mediated cytotoxicity in CD3+ leukemic large granular lymphocytes.
    Yoon HJ; Aprile JA; Loughran TP
    Cell Immunol; 1990 Dec; 131(2):404-8. PubMed ID: 2146989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The natural killer-related receptor for HLA-C expressed on T cells from CD3+ lymphoproliferative disease of granular lymphocytes displays either inhibitory or stimulatory function.
    Cambiaggi A; Orengo AM; Meazza R; Sforzini S; Tazzari PL; Lauria F; Raspadori D; Zambello R; Semenzato G; Moretta L; Ferrini S
    Blood; 1996 Mar; 87(6):2369-75. PubMed ID: 8630400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-CD3 monoclonal antibody-mediated cytotoxicity occurs through an interleukin-2-independent pathway in CD3+ large granular lymphocytes.
    Loughran TP; Aprile JA; Ruscetti FW
    Blood; 1990 Feb; 75(4):935-40. PubMed ID: 2302461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukemic CD3+ LGL share functional properties with their CD8+ CD57+ cell counterpart expanded after BMT.
    Mollet L; Fautrel B; Leblond V; Bergeron F; Merle-Béral H; Baumelou E; Hubert P; Debré P; Autran B
    Leukemia; 1999 Feb; 13(2):230-40. PubMed ID: 10025897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD3+CD16+NK1.1+B220+ large granular lymphocytes arise from both alpha-beta TCR+CD4-CD8- and gamma-delta TCR+CD4-CD8- cells.
    Koyasu S
    J Exp Med; 1994 Jun; 179(6):1957-72. PubMed ID: 8195719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of CD95/CD95 ligand-apoptotic pathway in CD3(+) large granular lymphocyte leukemia.
    Lamy T; Liu JH; Landowski TH; Dalton WS; Loughran TP
    Blood; 1998 Dec; 92(12):4771-7. PubMed ID: 9845544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of leukemic large granular lymphocytes by interleukin-2 via the p75 interleukin-2 receptor.
    Yoon HJ; Sugamura K; Loughran TP
    Leukemia; 1990 Dec; 4(12):848-50. PubMed ID: 2147047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-12 is involved in the activation of CD3+ granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes.
    Zambello R; Trentin L; Cassatella MA; Raimondi R; Cerutti A; Enthammer C; Facco M; Agostini C; Semenzato G
    Br J Haematol; 1996 Feb; 92(2):308-14. PubMed ID: 8602990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of induction of activation of human peripheral blood mononuclear cells with a non-activating form of anti-CD3 MoAb in autoimmune thyroid disease (AITD).
    Resetkova E; Arreaza G; Yoshikawa N; Morita T; Kim H; Carayon P; Volpé R
    Clin Exp Immunol; 1993 Mar; 91(3):397-403. PubMed ID: 8443962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects.
    Ortaldo JR; Mason AT; Gerard JP; Henderson LE; Farrar W; Hopkins RF; Herberman RB; Rabin H
    J Immunol; 1984 Aug; 133(2):779-83. PubMed ID: 6203980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of tumor necrosis factor-alpha and its specific 55-Kd and 75-Kd receptors in patients with lymphoproliferative disease of granular lymphocytes.
    Zambello R; Trentin L; Bulian P; Cassatella M; Raimondi R; Chisesi T; Agostini C; Semenzato G
    Blood; 1992 Oct; 80(8):2030-7. PubMed ID: 1327287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival signals in leukemic large granular lymphocytes.
    Epling-Burnette PK; Loughran TP
    Semin Hematol; 2003 Jul; 40(3):213-20. PubMed ID: 12876670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different signals for stimulation of proliferation and lymphokine secretion by a CD3+ WT31- cloned cytotoxic lymphocyte.
    Pawelec GP; Bühring HJ; Busch FW; Kalthoff F; Wernet P
    Cell Immunol; 1988 May; 113(2):329-40. PubMed ID: 2965987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of T-cell antigens in the cytolytic activities of large granular lymphocytes (LGLs) in patients with LGL lymphocytosis.
    Oshimi K; Oshimi Y; Akahoshi M; Kobayashi Y; Hirai H; Takaku F; Hattori M; Asano S; Kodo H; Nishinarita S
    Blood; 1988 Feb; 71(2):473-9. PubMed ID: 2447984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of human T cells with NK cell markers by staphylococcal enterotoxin A via IL-12 but not via IL-18.
    Ami K; Ohkawa T; Koike Y; Sato K; Habu Y; Iwai T; Seki S; Hiraide H
    Clin Exp Immunol; 2002 Jun; 128(3):453-9. PubMed ID: 12109440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CpG-oligodeoxynucleotides enhance T-cell receptor-triggered interferon-gamma production and up-regulation of CD69 via induction of antigen-presenting cell-derived interferon type I and interleukin-12.
    Kranzer K; Bauer M; Lipford GB; Heeg K; Wagner H; Lang R
    Immunology; 2000 Feb; 99(2):170-8. PubMed ID: 10692033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells.
    Vujanovic NL; Herberman RB; Olszowy MW; Cramer DV; Salup RR; Reynolds CW; Hiserodt JC
    Cancer Res; 1988 Feb; 48(4):884-90. PubMed ID: 3257412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.